196 related articles for article (PubMed ID: 23904154)
1. High tumor interstitial fluid pressure identifies cervical cancer patients with improved survival from radiotherapy plus cisplatin versus radiotherapy alone.
Milosevic MF; Pintilie M; Hedley DW; Bristow RG; Wouters BG; Oza AM; Laframboise S; Hill RP; Fyles AW
Int J Cancer; 2014 Oct; 135(7):1692-9. PubMed ID: 23904154
[TBL] [Abstract][Full Text] [Related]
2. Extended field radiotherapy with or without chemotherapy in patients with cervical cancer and positive para-aortic lymph nodes: a single institution retrospective review.
Ng BH; Rozita A; Adlinda A; Lee WC; Wan Zamaniah W
Asian Pac J Cancer Prev; 2015; 16(9):3827-33. PubMed ID: 25987044
[TBL] [Abstract][Full Text] [Related]
3. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Radiation Field Failure After Definitive Chemoradiation in Patients With Locally Advanced Cervical Cancer.
Bae HS; Kim YJ; Lim MC; Seo SS; Park SY; Kang S; Kim SH; Kim JY
Int J Gynecol Cancer; 2016 May; 26(4):737-42. PubMed ID: 26937749
[TBL] [Abstract][Full Text] [Related]
5. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
[TBL] [Abstract][Full Text] [Related]
6. Impact of epidermal growth factor receptor expression on disease-free survival and rate of pelvic relapse in patients with advanced cancer of the cervix treated with chemoradiotherapy.
Pérez-Regadera J; Sánchez-Muñoz A; De-la-Cruz J; Ballestín C; Lora D; García-Martín R; Sotoca A; Pérez-Ruiz E; Lanzós E
Am J Clin Oncol; 2011 Aug; 34(4):395-400. PubMed ID: 20859196
[TBL] [Abstract][Full Text] [Related]
7. Extended-field intensity-modulated radiotherapy and concurrent cisplatin-based chemotherapy for postoperative cervical cancer with common iliac or para-aortic lymph node metastases: a retrospective review in a single institution.
Zhang G; Fu C; Zhang Y; Wang J; Qiao N; Yang Q; Cheng Y
Int J Gynecol Cancer; 2012 Sep; 22(7):1220-5. PubMed ID: 22854654
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
Lim A; Sia S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
[TBL] [Abstract][Full Text] [Related]
9. Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer.
Fyles A; Milosevic M; Pintilie M; Syed A; Levin W; Manchul L; Hill RP
Radiother Oncol; 2006 Aug; 80(2):132-7. PubMed ID: 16920212
[TBL] [Abstract][Full Text] [Related]
10. Locally Advanced Cervical Cancer: Outcomes With Variable Adherence to Treatment.
Manders DB; Morón A; McIntire D; Miller DS; Richardson DL; Kehoe SM; Albuquerque KV; Lea JS
Am J Clin Oncol; 2018 May; 41(5):447-451. PubMed ID: 27258678
[TBL] [Abstract][Full Text] [Related]
11. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery.
Pu J; Qin SS; Ding JX; Zhang Y; Zhu WG; Yu CH; Li T; Tao GZ; Ji FZ; Zhou XL; Han JH; Ji YL; Sun JX
J Cancer Res Clin Oncol; 2013 Apr; 139(4):703-8. PubMed ID: 23328996
[TBL] [Abstract][Full Text] [Related]
13. Peritumoral interstitial fluid flow velocity predicts survival in cervical carcinoma.
Hompland T; Lund KV; Ellingsen C; Kristensen GB; Rofstad EK
Radiother Oncol; 2014 Oct; 113(1):132-8. PubMed ID: 25443501
[TBL] [Abstract][Full Text] [Related]
14. Daily low-dose Cisplatin-based concurrent chemoradiotherapy for the treatment of cervical cancer in patients 70 years or older.
Hanawa S; Mitsuhashi A; Usui H; Yamamoto N; Watanabe-Nemoto M; Nishikimi K; Uehara T; Tate S; Uno T; Shozu M
Int J Gynecol Cancer; 2015 Jun; 25(5):891-6. PubMed ID: 25811592
[TBL] [Abstract][Full Text] [Related]
15. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
[TBL] [Abstract][Full Text] [Related]
16. Salvage radiotherapy with or without concurrent chemotherapy for pelvic recurrence after hysterectomy alone for early-stage uterine cervical cancer.
Kim SW; Chun M; Ryu HS; Chang SJ; Kong TW; Lee EJ; Lee YH; Oh YT
Strahlenther Onkol; 2017 Jul; 193(7):534-542. PubMed ID: 28357468
[TBL] [Abstract][Full Text] [Related]
17. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
[TBL] [Abstract][Full Text] [Related]
18. Concurrent paclitaxel/cisplatin chemoradiotherapy with or without consolidation chemotherapy in high-risk early-stage cervical cancer patients following radical hysterectomy: preliminary results of a phase III randomized study.
Zhao H; Li L; Su H; Lin B; Zhang X; Xue S; Fei Z; Zhao L; Pan Q; Jin X; Xie C
Oncotarget; 2016 Oct; 7(43):70969-70978. PubMed ID: 27391158
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association.
Tattersall MH; Lorvidhaya V; Vootiprux V; Cheirsilpa A; Wong F; Azhar T; Lee HP; Kang SB; Manalo A; Yen MS
J Clin Oncol; 1995 Feb; 13(2):444-51. PubMed ID: 7844607
[TBL] [Abstract][Full Text] [Related]
20. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
Stock RG; Chen AS; Karasek K
Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
